BR9909357A - Solução ou suspensão de mirtazapina em mistura com água, formulação farmacêutica compreendendo mirtazapina, e, uso de mirtazapina - Google Patents
Solução ou suspensão de mirtazapina em mistura com água, formulação farmacêutica compreendendo mirtazapina, e, uso de mirtazapinaInfo
- Publication number
- BR9909357A BR9909357A BR9909357-0A BR9909357A BR9909357A BR 9909357 A BR9909357 A BR 9909357A BR 9909357 A BR9909357 A BR 9909357A BR 9909357 A BR9909357 A BR 9909357A
- Authority
- BR
- Brazil
- Prior art keywords
- mirtazapine
- water
- solution
- pharmaceutical formulation
- suspension mixed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98201037 | 1998-04-02 | ||
PCT/EP1999/002277 WO1999051237A1 (en) | 1998-04-02 | 1999-03-29 | Oral liquid antidepressant solution |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9909357A true BR9909357A (pt) | 2000-12-12 |
Family
ID=8233550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9909357-0A BR9909357A (pt) | 1998-04-02 | 1999-03-29 | Solução ou suspensão de mirtazapina em mistura com água, formulação farmacêutica compreendendo mirtazapina, e, uso de mirtazapina |
Country Status (12)
Country | Link |
---|---|
US (2) | US6040301A (de) |
EP (1) | EP1067934B1 (de) |
AT (1) | ATE254918T1 (de) |
AU (1) | AU747975B2 (de) |
BR (1) | BR9909357A (de) |
CA (1) | CA2326356C (de) |
DE (1) | DE69913116T2 (de) |
DK (1) | DK1067934T3 (de) |
ES (1) | ES2212550T3 (de) |
HK (1) | HK1032012A1 (de) |
PT (1) | PT1067934E (de) |
WO (1) | WO1999051237A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6495534B2 (en) | 2000-05-15 | 2002-12-17 | Pharmacia & Upjohn Spa | Stabilized aqueous suspensions for parenteral use |
ATE380884T1 (de) * | 2001-02-12 | 2007-12-15 | Organon Nv | Verwendung von mirtazapin zur verbesserung der behandlung von menschen mit starken depressionen, welche träger des gens für apolipoprotein e4 sind. |
US20030105082A1 (en) * | 2001-12-03 | 2003-06-05 | Murphy Greer Marechal | Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4 |
US6399310B1 (en) | 2001-02-12 | 2002-06-04 | Akzo Nobel N.V. | Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4 |
US20040156894A1 (en) * | 2003-02-07 | 2004-08-12 | Grother Leon Paul | Use of edible acids in fast-dispersing pharmaceutical solid dosage forms |
US7838029B1 (en) | 2003-07-31 | 2010-11-23 | Watson Laboratories, Inc. | Mirtazapine solid dosage forms |
TW200538100A (en) * | 2004-04-21 | 2005-12-01 | Akzo Nobel Nv | Mirtazapine salts |
WO2006023703A2 (en) * | 2004-08-20 | 2006-03-02 | Cypress Bioscience, Inc. | Method for treating sleep related breathing disorders |
EP1796635A2 (de) * | 2004-09-14 | 2007-06-20 | Molecular Therapeutics, Inc. | D-methionin-formulierung mit verbesserten biopharmazeutischen eigenschaften |
AU2005304751A1 (en) * | 2004-11-08 | 2006-05-18 | Shire Llc | Synergistic effects of combined administration of mirtazapine and a stimulant compound |
TW200631584A (en) * | 2004-11-15 | 2006-09-16 | Akzo Nobel Nv | A medicament related to mirtazapine for the treatment of hot flush |
WO2006055854A2 (en) * | 2004-11-17 | 2006-05-26 | Cypress Bioscience, Inc. | Methods for reducing the side effects associated with mirtazapine treatment |
WO2008157094A1 (en) * | 2007-06-13 | 2008-12-24 | Cypress Bioscience, Inc. | Improving the tolerability of mirtazapine and a second active by using them in combination |
CN102939436B (zh) | 2010-05-05 | 2016-03-23 | 能量转子股份有限公司 | 流体能量转换装置 |
US8714951B2 (en) * | 2011-08-05 | 2014-05-06 | Ener-G-Rotors, Inc. | Fluid energy transfer device |
WO2016138357A1 (en) | 2015-02-27 | 2016-09-01 | Kindred Biosciences, Inc. | Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL189199C (nl) * | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
US5208261A (en) * | 1989-12-06 | 1993-05-04 | Akzo N.V. | Stabilized solutions of psychotropic agents |
ATE99943T1 (de) * | 1989-12-06 | 1994-01-15 | Akzo Nv | Psychotropische wirkstoffe enthaltende stabilisierte loesungen. |
IE63986B1 (en) * | 1989-12-30 | 1995-06-28 | Akzo Nv | Pharmaceutical preparation for oral administration in fluid form |
US5238699A (en) * | 1991-11-27 | 1993-08-24 | Kraft General Foods, Inc. | Ready-to-eat, low/no-fat puddings and process |
-
1999
- 1999-03-29 DK DK99917956T patent/DK1067934T3/da active
- 1999-03-29 ES ES99917956T patent/ES2212550T3/es not_active Expired - Lifetime
- 1999-03-29 EP EP99917956A patent/EP1067934B1/de not_active Expired - Lifetime
- 1999-03-29 AU AU36048/99A patent/AU747975B2/en not_active Ceased
- 1999-03-29 PT PT99917956T patent/PT1067934E/pt unknown
- 1999-03-29 CA CA002326356A patent/CA2326356C/en not_active Expired - Fee Related
- 1999-03-29 WO PCT/EP1999/002277 patent/WO1999051237A1/en active IP Right Grant
- 1999-03-29 BR BR9909357-0A patent/BR9909357A/pt not_active Application Discontinuation
- 1999-03-29 DE DE69913116T patent/DE69913116T2/de not_active Expired - Lifetime
- 1999-03-29 AT AT99917956T patent/ATE254918T1/de active
- 1999-04-01 US US09/283,945 patent/US6040301A/en not_active Expired - Fee Related
- 1999-07-22 US US09/358,772 patent/US6114324A/en not_active Expired - Fee Related
-
2001
- 2001-04-20 HK HK01102818A patent/HK1032012A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU747975B2 (en) | 2002-05-30 |
US6040301A (en) | 2000-03-21 |
DK1067934T3 (da) | 2004-03-29 |
HK1032012A1 (en) | 2001-07-06 |
PT1067934E (pt) | 2004-03-31 |
US6114324A (en) | 2000-09-05 |
AU3604899A (en) | 1999-10-25 |
WO1999051237A1 (en) | 1999-10-14 |
EP1067934B1 (de) | 2003-11-26 |
ES2212550T3 (es) | 2004-07-16 |
DE69913116D1 (de) | 2004-01-08 |
CA2326356C (en) | 2008-06-03 |
ATE254918T1 (de) | 2003-12-15 |
DE69913116T2 (de) | 2004-06-03 |
CA2326356A1 (en) | 1999-10-14 |
EP1067934A1 (de) | 2001-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9909357A (pt) | Solução ou suspensão de mirtazapina em mistura com água, formulação farmacêutica compreendendo mirtazapina, e, uso de mirtazapina | |
BR0110841A (pt) | Suspensões aquosas estabilizadas para uso parenteral | |
BRPI0111639B8 (pt) | uso de uma molécula de ácido oligodeoxinucléico imunoestimulatório e composição farmacêutica. | |
BR0214757A (pt) | Formulações farmacêuticas de derivados de platina | |
NO970051L (no) | Vandige risperidon formuleringer | |
YU84703A (sh) | Oralni rastvor aripiprazola | |
TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
BR9917007A (pt) | Moduladores de ccr5 | |
NO20025450D0 (no) | Ny farmasöytisk sammensetning | |
BR0215042A (pt) | fenil-naftalenos substituìdos como agentes estrogênicos | |
EE9900465A (et) | Uued ühendid | |
HUP0203028A2 (hu) | Tolterodint tartalmazó gyógyszerkészítmény és alkalmazása | |
TR200101499T1 (tr) | Azepinoindol türevleri, hazırlanmaları ve kullanımları. | |
HRP20020198B1 (en) | Moxifloxacin formulation containing common salt | |
DE69818026D1 (de) | Wässrige suspension zur nasalen verabreichung von loteprednol | |
BR9909958A (pt) | Formulação farmacêutica, respectivos processo de preparação e uso e método de tratamento ou prevenção de distúrbios ósseos | |
BR0114379A (pt) | Derivados de c-ciclohexilmetilamina substituìdos | |
BR0104358A (pt) | Formulações de taxana tendo solubilidade aperfeiçoada | |
DK1204658T3 (da) | Benzofurylpiperazin-serotoninagonister | |
ATE201680T1 (de) | 2,3,4,5-tetrahydro-1h-3-benzazepin säure- additions-salze | |
DK1268522T3 (da) | LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler | |
YU87501A (sh) | Farmaceutski kompleksi | |
HUP9904030A2 (hu) | Tiagabin felhasználása pszichotikus rendellenességek kezelésére alkalmas gyógyszer előállítására | |
UY27372A1 (es) | Derivados de bencimidazol 1-aril-2-n, s u o-sustituidos, su uso para la obtención de medicamentos y preparados farmacéuticos que contienen estos derivados | |
PT1283042E (pt) | Preparação líquida aquosa de pranoprofeno |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DE INT.CL: A61K 31/55, A61K 9/08, A61K 9/10, A61P 25/24 Ipc: A61K 31/55 (2007.10), A61K 9/08 (2007.10), A61K 9/ |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE O MESMO NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA ( ARTIGOS 8O E 13 DA LPI ) |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |